Single Use Instrument recommendations set to stimulate reform in decontamination procedures?

Article

The recommendations for 'the use of single use instruments where possible' when performing 'high-risk' surgical procedures, has not only led to a growth in the single use market segment, but has stimulated massive reform in decontamination procedures, creating increased demand globally for reusable instruments due to new processes and longer lead times.

The recommendations for 'the use of single use instruments where possible' when performing 'high-risk' surgical procedures, has not only led to a growth in the single use market segment, but has stimulated massive reform in decontamination procedures, creating increased demand globally for reusable instruments due to new processes and longer lead times, according to ophthalmic instrument supplier John Weiss & Son, Ltd.

Although the heightened requirements for handcrafted reusable instruments remains a production priority for many manufacturers, the significant requirement for single use instruments alongside reusable products cannot be ignored.

This is evidenced by the foundation of The Eyeline Organisation, an international group of ophthalmologists whose aim is to apply cutting edge innovation to the design and quality of single use instruments. Eyeline manufactures instruments including forceps, needleholders, scissors and a variety of manipulators and probes. The ACROfine dispøz Single Use Instruments manufactured by Eyeline have recently been released by John Weiss, and are available in procedure packs for phaco, sub-tenons, oculoplastic, and intravitreal injections.

"This unique relationship will offer surgeons the single use solution they never expected," explains Michael Bench, managing director of John Weiss.

www.johnweiss.com

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Related Content
© 2025 MJH Life Sciences

All rights reserved.